The primary infection of Epstein-Barr virus (EBV) may result in fatal infectious mononucleosis or hemophagocytic syndrome (HPS) in two diseases, i.e., X-linked lymphoproliferative disorders (XLP) and hemophagocytic lymphohistiocytosis (HLH).
Introduction
The Epstein-Barr virus (EBV) can infect B cell, epithelial cell, and T or NK cell, resulting in a spectrum of benign and malignant human diseases. [1] [2] [3] [4] Although primary EBV infections usually run an uneventful course, a fatal form of infectious mononucleosis (IM) or hemophagocytic syndrome (HPS) characterized by hepatosplenomegaly, coagulopathy, pancytopenia, hypercytokinemia, and a systemic proliferation of macrophages with hemophagocytosis may develop in young children. [5] [6] [7] [8] [9] Among the EBV-associated HPS, two distinct disease entities, i.e., the X-linked lymphoproliferative disorders (XLP) 10 and a sporadic type hemophagocytic lymphohistiocytosis (HLH), 2 are of particular interest since they share common clinical phenotype and pathological features of HPS.
XLP is a genetic disorder which affects young boy and is characterized by an inappropriate immune response to primary EBV infection. 11 A few children may survive the initial episode of IM, but later develop dysgammaglobulinemia or progress to Burkitt's lymphoma. 10, 12 Although the exact pathobiology of XLP remains to be established, it has been proposed to result from an excessive or dysregulated T cell immune response to EBV-infected B lymphocytes. [13] [14] [15] [16] Recently, the majority of XLP patients were demonstrated to have mutations of a SH2D1A gene which encodes a signaling lymphocyte activation molecule (SLAM)-associated protein (SAP). [17] [18] [19] SLAM is a member of the immunoglobulin superfamily that is expressed on T and B cells and is capable of homotypic interaction. The antibody-mediated ligation of SLAM may induce T cell activation and enhance Th1 cytokine production. 20, 21 SAP may physically associate with SLAM via the SH2 domain and may displace the SH2 domain-bearing proteins such as SHP-2 from SLAM. 23, 24, 41 By this sense, SAP acts as For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From a natural suppressor or modulator of the SH2 domain-mediated interactions in SLAM-mediated T cell activation signals. 25 The mutation or deletion of SAP gene will result in absence or nonfunctioning of SAP protein and lead to abnormal T cell activation and enhanced Th1 cytokine production as demonstrated in XLP patients. 20, 25, 26 The pathomechanism of sporadic type HPS or HLH, however, is basically distinct from XLP in the lack of SAP/SH2D1A gene mutation and gender predilection. 27, 28 Furthermore, EBV directly infects T or NK cells in HLH, rather than the B cells in XLP. [29] [30] [31] [32] The EBV latent membrane protein-1 (LMP1) has been reported to activate T cells, upregulate tumor necrosis factor-alpha (TNF-E) and interferon-gamma (IFN-), and in turn activate macrophages and lead to an enhanced cytokine storm and hemophagocytosis. 16, 33, 34 Albeit there exist distinct differences for these two disease entities as described above, they share common manifestations of dysregulated T cell activation, enhanced Th1 cytokine secretion, and the subsequent development of fatal HPS. Therefore, the potential involvement of SAP/SH2D1A molecule in the LMP1-mediated signal pathway in HLH deserves to be elucidated. This study was therefore designed to clarify the potential role of SAP/SH2D1A in the pathomechanism of HLH in EBV-infected T cells. Interestingly, we demonstrated that EBV LMP1 can inhibit the expression of SAP/SH2D1A at the transcriptional level.
Tissue samples obtained from seven Taiwanese cases of HLH were evaluated for the mutation studies of SAP/SH2D1A gene. Since EBV LMP1 has been demonstrated to exert its function through the aggregation of cytoplasmic c-terminal domains, CTAR1
and CTAR-2, to recruit TRAF molecules in B and epithelial cells, resulting in the 
Materials and Methods

Patients and tissue samples
A total of 35 cases of childhood HPS were encountered in National Taiwan University Hospital and National Cheng Kung University Hospital during the period of 1991 to 2002. 37, 38 Tissues or freshly frozen cells were available for DNA and RNA extraction in seven cases, including lymph nodes in two, spleen in one, skin in one, and bone marrow in three. Ten specimens of reactive lymphoid hyperplasia (5 cases), IM (2 cases) and nasal type NK/T cell lymphoma (3 cases) were included for controls.
Informed consent was received from the patients according to the declaration of Helsinki. Approval for these studies was obtained from the National Health Research Institutes NHRI, Taiwan.
PCR amplification and Reverse-transcriptase PCR analysis of SAP/SH2D1A gene
In order to detect the mutations on the SAP/SH2D1A gene, we analyzed sequences of both genomic DNA and SAP gene transcripts. For detecting SAP gene mutation on the exon 2/3 as demonstrated previously on cases of XLP, 17 Genomic DNA of seven HLH cases were extracted for polymerase chain reaction (PCR) and automatic sequencing with the same primer sets described previously. 
Extraction of cytoplasmic and nuclear proteins
To study the protein expression in the cytoplasmic and nuclear fractions, 10 6 cells were added to 50ul buffer A containing 10mM HEPES-KOH, 1.5 mM MgCl 2 , and 10 mM KCl. After incubating on ice for 10 minutes, the mixtures were spinned down at 13,000 r.p.m. for 10 seconds. The supernatant fraction after the centrifugation represents the cytoplasmic protein lysate. The pellets were next resuspended with 100ul buffer B containing 20mM HEPES-KOH, 1.5 mM MgCl2, 0.2mM EDTA, and 25% glycerol. The mixtures were incubated on ice for 20 minutes and spinned down at 13,000 r.p.m. for 2 minutes, and the supernatants represent the nuclear protein fractions. Alpha-actin and histone H1 were used as the controls for correct preparations of the cytoplasmic and nuclear fraction proteins, respectively. 
Antibodies and reagents
NF-%B Promoter Reporter assays
To evaluate NF-MB activity, reporter assay using a NFMB-site dependent luciferase vector p6x MB-Luc was performed as previously described. 
Enzyme-linked Immunosorbent Assay (ELISA)
In order to examine the effects of SAP and dominant negative TRAF2/5 on IFN-secretion, secreted IFN-cytokine levels in culture supernatants of H9 cells were measured by IFN-ELISA kit (Biosource International, Camarillo, CA, USA) as described previously. 33 Culture supernatants were harvested by filtration through a 0.45 µm pore size filter (Costar, Cambridge, MA, USA) to exclude cell debris.
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Results
No detectable mutations on exon 2/3 of SAP/SH2D1A gene in seven sporadic
HLH patients
The pertinent clinical and laboratory data of seven HLH cases including four male and three female patients, with a mean age of 16.7 years, were summarized in Table 1 . Three cases responded to the therapy using a protocol of IVIG/VP-16, 38 two had chronic active diseases, and two had rapidly progressive diseases.
Sequence analyses of the SAP/SH2D1A gene and its transcripts on HLH cases revealed no mutation on exons 2/3, nor did that of the control specimens. 
Discussion
For many decades, clinicians and investigators are puzzled by the differential diagnosis between XLP and sporadic type HLH when encountered a young boy presenting with EBV-associated HPS. The recent discovery of the linkage of XLP to the mutations of SAP/SH2D1A gene provides a major breakthrough in this regard. 17, 45 However, there still remain a substantial population of HPS cases, either with or without EBV association, which show no detectable mutation on the SAP/SH2D1A gene, as demonstrated in our cases and from other reports. 28 Given that EBV infects T or NK cells in sporadic HLH, instead of the B cells in XLP, we initially speculate that these two diseases may adopt different mechanism to respond to primary EBV infection. In this study, we demonstrate that EBV LMP1 protein could effectively suppress the expression of SAP/SH2D1A gene in T cells, as previously shown in Burkitt's lymphoma cells, 46 at the transcriptional level and thereby both XLP and sporadic HLH share common signal pathway, through either the mutation or the LMP1-mediated suppression of SAP/SH2D1A gene, finally leading to overt T cell activation and enhanced Th1 cytokine secretion in response to primary EBV infection.
In this study, the seven HLH cases showed no detectable mutations of SAP/SH2D1A gene at exon2/3. The EBV has been previously shown to infect T cells in these cases as demonstrated by double-labeled immunohistochemistry and EBER1 in situ hybridization in six of our HLH cases. 47 Taken together, these results further support the distinction of our 7 HLH cases from XLP. Recently, a familial disease entity of chronic active EBV infection with HPS has been shown to have mutations of the perforin gene. 48 Although no study of perforin gene mutation was performed in this study, the absence of familial aggregation in our patients may reasonably exclude familial HLH cases. Ras-GAP. 22, 44 Therefore, the mutation of SAP gene in XLP patients or knocking out of SAP/SH2D1A gene in mouse T cells may result in high levels of Th1 cytokines. 20, 49 Recently, SAP has been demonstrated to engage in the control of cytolytic activity by polarization of the lytic machinery involving 2B4 and CD84. pathway. Previously, we demonstrated that EBV infection and LMP1 transfection of T cells could upregulate TNF-. 33, 34 In this study, we further demonstrated that LMP1 expression could enhance IFN-secretion. Therefore, both Th1 cytokines TNF-and IFN-could be upregulated by LMP1 expression in T cells.
Although no mutation of SAP/SH2D1A gene could be detected in EBV-HLH patients, our results showed that the reduced SAP gene expression could be achieved through LMP1-mediated signaling in sporadic HLH. Therefore, our data shown in this study reconcile the difference in the molecular background of XLP and sporadic HLH and both diseases appear to share common pathogenesis of HPS to elicit abnormal T cell activation and activate macrophages and cytokine storm in response to primary EBV infection as shown in Figure 5 . For personal use only. on November 12, 2017. by guest www.bloodjournal.org From
